A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure

American Heart Journal

Volumn 153, Issue 5, 2007, Pages 868-873

  Gottlieb, Stephen S ^a   Kop, Willem J ^a   Thomas, Sue A ^a   Katzen, Scott ^a   Vesely, Mark R ^a   Greenberg, Nancy ^a   Marshall, Joanne ^a   Cines, Michelle ^a   Minshall, Stacey ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE;

ADULT; AIR CONDITIONING; ARTICLE; BREATHING EXERCISE; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OSCILLATION; OXYGEN CONSUMPTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RESPIRATORY TRACT DISEASE; SENSITIVITY AND SPECIFICITY; UNIVARIATE ANALYSIS;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHRONIC DISEASE; DELAYED-ACTION PREPARATIONS; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; PILOT PROJECTS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 34247152905     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.02.024     Document Type: Article

References (29)

1. Rutledge T., Reis V.A., Linke S.E., et al. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48 (2006) 1527-1537
2. Gottlieb S.S., Khatta M., Friedmann E., et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol 43 (2004) 1542-1549
3. Havranek EP, Ware MG, Lowes BD. Prevalence of depression in congestive heart failure. Am J Cardiol 1999;84:348-50.
4. Rozzini R., Sabatini T., Frisoni G.B., et al. Depression and major outcomes in older patients with heart failure. Arch Intern Med 162 (2002) 362-364
5. Rumsfeld J.S., Havranek E., Masoudi F.A., et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 42 (2003) 1811-1817
6. Koenig H.G. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 20 (1998) 29-43
7. Ruo B., Rumsfeld J.S., Hlatky M.A., et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA 290 (2003) 215-221
8. Carels R.A. The association between disease severity, functional status, depression and daily quality of life in congestive heart failure patients. Qual Life Res 13 (2004) 63-72
9. Jiang W., Alexander J., Christopher E., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161 (2001) 1849-1856
10. Vaccarino V., Kasl S.V., Abramson J., et al. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 38 (2001) 199-205
11. Murberg T.A., Bru E., Svebak S., et al. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow-up study. Int J Psychiatry Med 29 (1999) 311-326
12. Faris R., Purcell H., Henein M.Y., et al. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 4 (2002) 541-551
13. Braunwald E. Heart disease. 3rd ed. (1988), WB Saunders, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo
14. Glassman A.H., O'Connor C.M., Califf R.M., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002) 701-709
15. Roose S.P., Laghrissi-Thode F., Kennedy J.S., et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA 279 (1998) 287-291
16. Beck A.T., Steer R.A., and Brown C. The Beck depression inventory manual. 2nd ed. (1996), The Psychological Corporation, San Antonio (Tex)
17. Rush A.J., Giles D.E., Schlesser M.A., et al. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 18 (1986) 65-87
18. Strik J.J., Honig A., Lousberg R., et al. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 42 (2001) 423-428
19. Frasure-Smith N., Lesperance F., and Talajic M. Depression following myocardial infarction. impact on 6-month survival. JAMA 270 (1993) 1819-1825
20. Frasure-Smith N., Lesperance F., and Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91 (1995) 999-1005
21. Kop W.J., and Ader D.N. Assessment and treatment of depression in coronary artery disease patients. Ital Heart J 2 (2001) 890-894
22. Ware J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
23. Rector T.S., Kubo S.H., and Cohn J.N. Patient's self assessment of their congestive heart failure. Part 2. Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Fail 3 (1987) 198-209
24. Rector T.S., Kubo S.H., and Cohn J.N. Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol 71 (1993) 1106-1107
25. Lesperance F., Frasure-Smith N., Laliberte M.A., et al. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure. Can J Psychiatry 48 (2003) 695-701
26. Carney R.M., Freedland K.E., Miller G.E., et al. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 53 (2002) 897-902
27. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 55 (1998) 580-592
28. Pasic J., Levy W.C., and Sullivan M.D. Cytokines in depression and heart failure. Psychosom Med 65 (2003) 181-193
29. Serebruany V.L., Glassman A.H., Malinin A.I., et al. Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin. Eur J Heart Fail 5 (2003) 517-521